InWillcox & Gibbs Sewing Machine Co. v. Ewing, supra [141 U.S. 627, 12 S.Ct. 95, 35 L.Ed. 882], defendant company had appointed plaintiff as its "exclusive vendor" in a defined territory, and had agreed to sell him its machines at a large discount from its retail New York prices. It further agreed that it would not knowingly supply its goods at a discount to go within that territory. The plaintiff accepted the appointment and agreed to pay for the machines at the discount rate; not to sell them below the retail rate; and not to solicit orders in the territory of other agents. It was further agreed that plaintiff's time, attention, and abilities "must primarily be devoted to the forwarding of the interest" of defendant, and that the "appointment or agency" was not saleable or transferable by plaintiff without defendant's consent. When defendant discharged plaintiff and terminated the contract, plaintiff sued for breach of a sales agreement. The court held that the contract was one of agency and that, inasmuch as plaintiff had the right to terminate it on reasonable notice, the defendant had the same right in default of stipulations to the contrary.

Question 1

1. Is it safe to give piracetam to patients with primary intracerebral

haemorrhage? Does it have a neuroprotective effect?

2. Is it safe to give a patient with excessively high blood pressure

(as a sequela to recent primary intracerebral haemorrhage)

angiotensin-converting enzyme inhibitors to lower the blood

pressure?

3. Is it indicated to give piracetam or vincamine to a patient with middle

cerebral artery territorial infarction? Do these have any neuroprotective

effect?

Question 2

What is the mechanism by which subarachnoid haemorrhage is

associated with subhyaloid haemorrhages on fundus examination, and

how can cerebrospinal fluid (CSF) gain access to the subhyaloid space

inside the eye?

Question 3

What is the recommended dosage for nimodipine given intravenously in

cases of subarachnoid haemorrhage, and when should the treatment

start? For how long should the dose be continued?

Question 4

I read recently that hyperuricaemia has something to do with stroke? Is it

recommended to give allopurinol to stroke patients irrespective of their

serum uric acid?

Question 5

Is there a link between hyperuricaemia (although asymptomatic) and

atherosclerosis and cerebral ischaemic stroke?

Question 6

Are phenytoin and carbamazepine indicated in myoclonus, occasionally

seen in ischemic strokes?

Question 7

What is the treatment of chorea or action myoclonus resulting from

embolic stroke to the area of basal ganglia? Does the L-dopa that is given

by some neurologists improve the condition? Does valproate have a role

if the case is action myoclonus?

Question 8

How should a patient with a haemorrhagic cerebrovascular accident

be managed while also having an extensive inferior wall myocardial

infarction?

Question 9

What is the best way to manage cortical vein thrombosis? If heparin is to

be used, what is the recommended dosage and how long should this

treatment last?

Question10

In the case of cortical vein thrombosis, for how long should

anticoagulation be continued?7180